Botswana Pediatric Respiratory Disease and Bloodstream Infection Study

Overview

The purpose of this study is to learn about lower respiratory tract and bloodstream diseases among infants born to HIV positive mothers in Botswana. Study factors include how commonly infants get these diseases, the causes, and outcomes. The study will also try to measure the protective effect, if any, of breast feeding on respiratory disease illness and deaths.

Full Title of Study: “Botswana Pediatric Respiratory Disease and Bloodstream Infection”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: October 2005

Interventions

  • Procedure: blood draws, etc.

Clinical Trial Outcome Measures

Primary Measures

  • OCCURRENCE OF SUSPECTED PNEUMONIA OR BLOODSTREAM INFECTION OVER FIRST TWO YEARS OF LIFE
    • Time Frame: Between birth and 2 years of life
    • MORTALITY; EPISODES OF SUSPECTED PNEUMONIA; BACTEREMIA; PRESENCE OF NASOPHARYNGEAL VIRAL PATHOGENS; OROPHARYNGEAL COLONIZATION WITH BACTERIAL PATHOGENS

Participating in This Clinical Trial

Inclusion Criteria

  • Participation in parent study, "Mashi" HIV vertical transmission prevention study for pregnant Botswana women and their infants

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Harvard School of Public Health (HSPH)
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Shahin Lockman, MD, Principal Investigator, Harvard School of Public Health (HSPH)

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.